Strategies to assist with adverse event management and patient-led decision making

Shared decision making and adverse event (AE) management are important for haematologists to consider in their day to day management of patients with multiple myeloma. As part of the Amgen Multiple Myeloma webinar series Dr Brian Durie, Chairman of the Board of the International Myeloma Foundation, International Myeloma Working Group and specialist at the Cedars-Sinai ...